Effects of Instrument Assisted Soft Tissue Mobilization Regarding Range of Motion and Lower Extremity Power

NCT06610058 | Completed

• 1 other identifier: 2428
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy adult volunteers. The main questions it aims to answer are:

• Does IASTM treatment have an effect on range of motion (ROM) as measured in the hip, knee and ankle?
• Does IASTM treatment have an effect on lower extremity power? Researchers will compare pre-test and post-test IASTM treatment intervention data to the pre-test and post-test data of the no treatment control intervention to see if IASTM works to change range of motion and/or lower extremity power. Participants will:
• Complete a questionnaire on medical history and injury background
• Have hip, knee and ankle range of motion (ROM) measurements taken on both lower extremities using a goniometer
• Complete three trials of vertical jump testing using a Fleage Floor standing vertical jump measurement tester with one warm up first
• Complete three trials of horizontal jump testing using a Woanger 12'x2.5' long jump mat and verified by a secondary measure using a tape measure with one warm up first
• Be randomly assigned to either IASTM first treatment group or the wait/control first group
• Receive IASTM treatment techniques including application of emollient to the skin to reduce friction on the surface followed by scanning the hamstrings, quadriceps, gastroc/soleus complex, and Achilles tendon using the HG8-Scanner tool for 15 strokes in each direction. Then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) for 15 strokes in each direction.
• Simply wait for 20 minutes (the duration of time treatment with IASTM would require) when completing the control treatment.
• Complete hip, knee and ankle range of motion and vertical and horizontal jump measure testing at the end of the first session.
• Return within fourteen days after the first session in order to undergo the opposite experience (IASTM first means wait/control second and vice versa).
• Undergo the same baseline pre-test measurements for range of motion and vertical and horizontal jump measure testing as the first session.
• Experience the opposite treatment for the same time period as the first session.
• Undergo the post-test range of motion and vertical and horizontal jump measure testing at the end of the second session for data comparison.

Conditions

Healthy

Keywords

Instrument Assisted Soft Tissue Mobilization; Range of Motion; Lower Extremity Power; Vertical Jump; Horizontal Jump

Outcome Measures

Primary Outcomes (3)

• Range of Motion

  Bilateral hip flexion, extension and abduction, knee flexion and extension, ankle plantarflexion, dorsiflexion, inversion and eversion range of motion measurements were taken in supine or prone (whichever was appropriate) using a goniometer.

  From baseline to end of session at one hour

• Lower Extremity Power Horizontal Jump

  Lower extremity power was measured by completing three trials of horizontal jump testing using a Woanger 12'x2.5' long jump mat with the distance verified by a secondary measure using a tape measure with one warm up first and 90 seconds to recover between each jump.

  From baseline to end of session at one hour

• Lower Extremity Power Vertical Jump

  Lower extremity power was measured by completing three trials of vertical jump testing using a Fleage Floor standing vertical jump measurement tester with one warm up first and 90 seconds to recover between each jump.

  From baseline to end of session at one hour

Study Arms (2)

IASTM First

EXPERIMENTAL

This arm of the study received IASTM treatment on the first day and the wait/control on the second day of the study

Other: Instrument Assisted Soft Tissue Mobilization first Control second

Wait/control First

EXPERIMENTAL

This arm of the study waited (was the control) on the first day and received IASTM treatment on the second day of the study.

Other: Control first Instrument Assisted Soft Tissue Mobilization second

Interventions

Instrument Assisted Soft Tissue Mobilization first Control second OTHER

Instrument assisted soft tissue mobilization was utilized first on day one and wait-control was completed on second day.

IASTM First

Control first Instrument Assisted Soft Tissue Mobilization second OTHER

This intervention involved waiting for 20 minutes between pre-test and post-test on day one and having Instrument Assisted Soft Tissue Mobilization on day two.

Wait/control First

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Individuals from a small regional university student body, faculty and staff may choose to volunteer to participate in this study.

You may not qualify if:

• Acute spinal cord injury with neurological deficits
• Neurological disorders
• Acute lower extremity injury such as sprain or strain
• Acute lower extremity pain causing gait deviation
• Any type of lower extremity fracture within the past 12 months
• Lumbar disc pathology with radicular symptoms
• Use of blood thinning or clotting medications
• Known connective tissue disorder

Sponsors & Collaborators

• Beth Marschner: lead
• Minot State University: collaborator

Study Sites (1)

Minot State University

Minot, North Dakota, 58707, United States

Location

Study Officials

• Beth Marschner, DPT

  Minot State University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: September 18, 2024
• First Posted: September 24, 2024
• Study Start: January 8, 2024
• Primary Completion: February 29, 2024
• Study Completion: February 29, 2024
• Last Updated: September 24, 2024

Record last verified: 2024-09

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)